SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Arena Pharmaceuticals, Inc. Initiates Phase 1 Multiple Dose Clinical Trial of APD811 for Pulmonary Arterial Hypertension
Your Message